Canine adenovirus type 1 (CAV-1)
infection results in
hepatitis in
dogs. In this study, we investigated the
biologic and genetic characteristics of the CAV-1
vaccine strain (CAV1V) to improve
quality control about CAV
vaccine. The identity of CAV1V as CAV-1 was confirmed based on its cytopathic effects and the results of
hemagglutination (HA) and
immunofluorescence assays, and
electron microscopy. The CAV1V
strain reached 10(7.5) TCID(50)/mL in
MDCK cells at 4 days post-inoculation and exhibited hemmagglutination activity of 256 U using
guinea pig erythrocytes. Intranuclear
fluorescence in the infected
cells was observed and typical
adenoviruses were observed in electon microscope. CAV1V
strain was identified as a CAV-1
strain by
nucleotide sequence analysis. In a comparison of the
nucleotide sequences of the fiber
genes of several CAV
strains, CAV1V showed the highest similarity (99.8%) with the GLAXO
strain, which was isolated in
Canada. Our
biological characterization of CAV1V
will facilitate
quality control of the canine
hepatitis vaccine.